App-Quantinova.ai

Potential Multifactorial Mechanisms for Hormone‐induced Venous Thromboembolism

X. Yu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Fibrinogen (IV)

Knockout of von Willebrand Factor in Zebrafish by CRISPR/Cas9 Mutagenesis

N. Iyer - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Different Protein Spectrum in Patients with Venous Thrombosis after Lower Leg Plaster Cast Application or Knee Arthroscopy than in Controls

Y. Mohammed - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Prognostic Value of Elevated D‐Dimer Level after 1 Month of Anticoagulant Therapy in Patients with Venous Thromboembolism: Results of the 10‐year Follow‐up

N. Vorobyeva - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Warfarin

A Clinical‐genetic Risk Score to Predict Cancer‐associated Venous Thromboembolism: A Development and Validation Study in Two Independent Prospective Cohorts

A. Muoz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

The Rare MAST2 Arg89Gln Mutation Causes Venous Thrombosis in a French Family with Unexplained Thrombophilia: The Breizh MAST2 Mutation

P.-E. Morange - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Development and Validation of a Plasma micro‐RNAs Profile Associated with Venous Thrombosis

A. Rodriguez-Rius - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Generating Plasma Protein Signatures for Murine Venous Thrombosis and Slc44a2 Deficiency Using a Multiplex Targeted Proteomics Approach

J. Tilburg - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Protein C

Targeted Drug Therapy: Effective and Localised Anticoagulation without Bleeding Risks

X. Wang - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Novel Murine Venous Thromboembolism Model to Evaluate Role of Factor XIII in Pulmonary Embolism Risk

S. Kattula - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Evithrom

Venous Thrombosis and Thrombocyte Activity in Zebrafish Models of Quantitative and Qualitative Human Fibrinogen Disorders

C. Freire Sanz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Fibrinogen (IV)

Rare Bleeding Disorders in the Netherlands ‐ Update

J.L. Saes - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Targeting Protease Nexin‐1, a Natural Anticoagulant, to Control Bleeding in Hemophilia A

K. Aymonnier - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Evithrom

Platelet Physiology and Function in Neonates and Children from Different Pathways onto Extracorporeal Membrane Oxygenation (ECMO)

H.P. Yaw - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Venous thrombosis

Evithrom

Predictors of Recurrence and Post Thrombotic Syndrome (PTS) Following Lower Extremity Deep Vein Thrombosis in Children and Adolescents: PTS Risk Reduction Using Thrombolysis As Initial Therapy

M. Manco-Johnson - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Evithrom

Inherited Antithrombin Deficiency and Thrombosis in Childhood: Data from a Large Multicentric Cohort

C. Orlando - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Safety of Dabigatran Etexilate for Secondary Prevention of Venous Thromboembolism in Paediatric Patient

L. Brandao - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Pradax

Efficacy and Safety of Dabigatran Etexilate for Treatment of Venous Thromboembolism in Paediatric Patients ‐ Results of the DIVERSITY Trial

M. Albisetti - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Heparin

Unexpected Redundant Function of Twinfilin1 and Cofilin Is Essential for Platelet Biogenesis

I. Becker - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

High Thymic Stromal Lymphopoietin (TSLP) Expression Promotes Platelet Activation and Thrombosis in Kawasaki Disease via Promoting Mitophagy

X. Gu - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Phosphatidylserine

Filters

7277 Abstracts